retatrutide clinical trial safety UK: Progress, Expected Availability, and Guidance (2026) ESC 2024: Retatrutide improves lipid

doi: 10.1056/NEJMoa2032183 52 WaddenTABaileyTSBillingsLKDaviesMFriasJPKorolevaAet al

M., Husain, M., & Drucker, D

For example, with telogen effluvium you may lose about 300 hairs a day instead of 100, on average, leading to a noticeable hair loss

This is likely to expand as the NICE guidance is updated

If this happens consistently, switch to a shorter needle, use a 45-degree angle instead of 90 degrees, or choose a site with more subcutaneous tissue like the abdomen

A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease